Flows and flaws in primary central nervous system lymphoma

Nat Rev Clin Oncol. 2010 Aug;7(8):doi:10.1038/nrclinonc.2010.9-c1; author reply doi:10:1038/nrclinonc.2010.9-c2. doi: 10.1038/nrclinonc.2010.9-c1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Algorithms
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Central Nervous System Neoplasms / diagnosis
  • Central Nervous System Neoplasms / drug therapy
  • Central Nervous System Neoplasms / pathology*
  • Cytarabine / therapeutic use
  • Decision Making
  • Drug Therapy, Combination
  • Humans
  • Lymphoma, Non-Hodgkin / diagnosis
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / pathology*
  • Methotrexate / therapeutic use
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Cytarabine
  • Methotrexate